SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009664
Filing Date
2022-05-12
Accepted
2022-05-12 16:10:52
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-20220331.htm   iXBRL 10-Q 1950887
2 EX-10.1 bolt-ex10_1.htm EX-10.1 282053
3 EX-31.1 bolt-ex31_1.htm EX-31.1 16845
4 EX-31.2 bolt-ex31_2.htm EX-31.2 16800
5 EX-32.1 bolt-ex32_1.htm EX-32.1 8770
6 EX-32.2 bolt-ex32_2.htm EX-32.2 10049
  Complete submission text file 0000950170-22-009664.txt   7521486

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bolt-20220331_pre.xml EX-101.PRE 304788
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bolt-20220331_cal.xml EX-101.CAL 47061
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bolt-20220331_lab.xml EX-101.LAB 410522
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bolt-20220331_def.xml EX-101.DEF 170073
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bolt-20220331.xsd EX-101.SCH 54936
56 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20220331_htm.xml XML 1323379
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 22917898
SIC: 2834 Pharmaceutical Preparations